The Impact of Inflammatory Bowel Disease in Canada 2018: IBD Research Landscape in Canada.
The Impact of Inflammatory Bowel Disease in Canada 2018: IBD Research Landscape in Canada.
复制标题
DOI：
10.1093/jcag/gwy057
复制
发表时间：
2019-02-01
影响因子：
--
通讯作者：
Lee, Kate
中科院分区：
文献类型：
--
作者：
Rose, Keeley L;Sherman, Philip M;Lee, Kate
背景：加拿大的健康研究由政府、健康慈善机构、基金会和行业资助。我们调查了2013年至2017年期间加拿大IBD研究资金的水平以及该研究的科学影响。方法：使用加拿大卫生研究院（CIHR）资助的研究数据库和UberResearch的Dimensions平台对全球和加拿大IBD研究资金进行分析。提供了加拿大优先驱动和制药商发起的IBD研究的例子。使用文献计量学分析来评估加拿大IBD研究成果的质量。结果：2013年至2017年，加拿大IBD研究的总资金超过1.19亿加元（CAD），CIHR是最大的资助者，贡献了近6600万加元，克罗恩病和结肠炎加拿大投资超过3200万加元。加拿大在国际上排名第四。比较分析表明，加拿大IBD研究人员的出版物比其他加拿大和国际比较者的影响更大。当IBD研究的生产力和影响力相结合时，加拿大是世界前三名之一。结论：在加拿大IBD研究的投资导致了一个强大的研究人员合作小组的发展，产生了有影响力的，世界一流的研究。在学术生产力和影响力的所有指标上，加拿大在国际上排名前二或前三。未来的挑战是继续资助创新的IBD研究并培养下一代IBD研究人员，同时将研究结果转化为卫生政策和实践的变化，以使受影响的患者及其家人受益，并最终找到病因并确定治愈方法。
BACKGROUND: Health research in Canada is funded by government, health charities, foundations and industry. We investigated levels of IBD research funding and the scientific impact of this research in Canada between 2013 and 2017.METHODS: An analysis of global and Canadian funding in IBD research was conducted using the Canadian Institutes of Health Research (CIHR) Funded Research Database and UberResearch's Dimensions platform. Examples of priority-driven and investigator-initiated IBD research in Canada are provided. Bibliometric analysis was used to assess the quality of IBD research output in Canada.RESULTS: Total funding for IBD research Canada between 2013 and 2017 was over $119 million Canadian dollars (CAD), with CIHR, the largest funder, contributing almost $66 million CAD, and Crohn's and Colitis Canada, investing more than $32 million CAD. This ranks Canada fourth internationally. A comparative analysis indicates that publications by Canadian IBD researchers have a greater impact than other Canadian and international comparators. When productivity and impact in IBD research are combined, Canada is among the top three in the world.CONCLUSIONS: Investment in IBD research in Canada has resulted in the development of a strong collaborative group of researchers producing impactful, world-class research. On all measures of academic productivity and influence, Canada ranks in the top two or three internationally. The challenges ahead are to continue to fund innovative IBD research and grow the next generation of IBD researchers while moving research findings into changes in health policy and practice in order to benefit affected patients and their families-and ultimately, to find the cause(s) and identify the cure(s).